Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

APC I1307K and the risk of prostate cancer.

Poynter JN, Cooney KA, Bonner JD, White KA, Tomsho LP, Rennert G, Gruber SB.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):468-73.

2.

No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.

Abrahamson J, Moslehi R, Vesprini D, Karlan B, Fishman D, Smotkin D, Ben David Y, Biran H, Fields A, Brunet JS, Narod SA.

Cancer Res. 1998 Jul 15;58(14):2919-22.

3.

Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients.

Lehrer S, McCurdy LD, Stock RG, Kornreich R, Stone NN, Eng C.

Cancer Genet Cytogenet. 2000 Oct 15;122(2):131-3.

PMID:
11106824
4.

Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.

Zauber NP, Sabbath-Solitare M, Marotta S, Zauber AG, Foulkes W, Chan M, Turner F, Bishop DT.

Cancer. 2005 Aug 15;104(4):719-29.

5.

Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) gene.

Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG, Stone M, Bajwa A, Kornreich R.

Urol Oncol. 2003 Mar-Apr;21(2):101-4.

PMID:
12856637
6.

The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.

Petrukhin L, Dangel J, Vanderveer L, Costalas J, Bellacosa A, Grana G, Daly M, Godwin AK.

Cancer Res. 1997 Dec 15;57(24):5480-4.

7.

APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.

Stern HS, Viertelhausen S, Hunter AG, O'Rourke K, Cappelli M, Perras H, Serfas K, Blumenthall A, Dewar D, Baumann E, Lagarde AE.

Gastroenterology. 2001 Feb;120(2):392-400.

PMID:
11159880
8.

The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.

Locker GY, Kaul K, Weinberg DS, Gatalica Z, Gong G, Peterman A, Lynch J, Klatzco L, Olopade OI, Bomzer CA, Newlin A, Keenan E, Tajuddin M, Knezetic J, Coronel S, Lynch HT.

Cancer Genet Cytogenet. 2006 Aug;169(1):33-8.

PMID:
16875934
9.

How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.

Dundar M, Caglayan AO, Saatci C, Karaca H, Baskol M, Tahiri S, Ozkul Y.

Cancer Genet Cytogenet. 2007 Sep;177(2):95-7.

PMID:
17854661
10.

Colorectal polyps in carriers of the APC I1307K polymorphism.

Rennert G, Almog R, Tomsho LP, Low M, Pinchev M, Chaiter Y, Bonner JD, Rennert HS, Greenson JK, Gruber SB.

Dis Colon Rectum. 2005 Dec;48(12):2317-21.

11.

The I1307K polymorphism of the APC gene in colorectal cancer.

Prior TW, Chadwick RB, Papp AC, Arcot AN, Isa AM, Pearl DK, Stemmermann G, Percesepe A, Loukola A, Aaltonen LA, De La Chapelle A.

Gastroenterology. 1999 Jan;116(1):58-63.

PMID:
9869603
12.

Genetic analyses in consecutive israeli jewish colorectal cancer patients.

Fidder HH, Figer A, Geva R, Flex D, Schayek H, Avidan B, Meir SB, Friedman E.

Am J Gastroenterol. 2005 Jun;100(6):1376-80.

PMID:
15929773
13.

Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.

Silverberg MS, Clelland C, Murphy JE, Steinhart AH, McLeod RS, Greenberg GR, Cohen Z, Siminovitch KA.

Hum Genet. 2001 Mar;108(3):205-10.

PMID:
11354631
14.

Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.

Rozen P, Naiman T, Strul H, Taussky P, Karminsky N, Shomrat R, Samuel Z, Yaron Y, Orr-Urtreger A.

Cancer. 2002 May 15;94(10):2561-8.

15.

The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer.

Yuan ZQ, B├ęgin LR, Wong N, Brunet JS, Trifiro M, Gordon PH, Pinsky L, Foulkes WD.

Br J Cancer. 1999 Nov;81(5):850-4.

16.

Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.

Gryfe R, Di Nicola N, Lal G, Gallinger S, Redston M.

Am J Hum Genet. 1999 Feb;64(2):378-84.

17.

Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer.

Rozen P, Shomrat R, Strul H, Naiman T, Karminsky N, Legum C, Orr-Urtreger A.

Gastroenterology. 1999 Jan;116(1):54-7.

PMID:
9869602
18.

The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.

Strul H, Barenboim E, Leshno M, Gartner M, Kariv R, Aljadeff E, Aljadeff Y, Kazanov D, Strier L, Keidar A, Knaani Y, Degani Y, Alon-Baron L, Sobol-Dvory H, Halpern Z, Arber N.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1012-5.

19.

Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland.

Matikaine MP, Pukkala E, Schleutker J, Tammela TL, Koivisto P, Sankila R, Kallioniemi OP.

Cancer Causes Control. 2001 Apr;12(3):223-30.

PMID:
11405327
20.

RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients.

Orr-Urtreger A, Bar-Shira A, Bercovich D, Matarasso N, Rozovsky U, Rosner S, Soloviov S, Rennert G, Kadouri L, Hubert A, Rennert H, Matzkin H.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):474-9.

Supplemental Content

Support Center